Professor Lim Haegyun of Pukyong National University Selected for Outstanding Research on Targeted Cancer Cell Therapy Using Ultrasound
Ministry of Science and ICT Excellent Young Researcher Program... 1.2 Billion KRW Solo Research Project Over 5 Years
Pukyong National University announced on the 16th that Professor Lim Haegyun (Department of Biomedical Engineering) has been selected for the "2024 Excellent Young Researcher Program for Basic Research Projects," organized by the Ministry of Science and ICT and the National Research Foundation of Korea.
Professor Lim Haegyun conducted research on "Development of a Non-Invasive, Remotely Controlled Acoustic Tweezer-Sonogenetics-Based Wearable Device for Immuno-Oncology Therapy" as part of this project.
The Excellent Young Researcher Program is a government-funded R&D initiative that supports creative research by young researchers and aims to foster their research capabilities.
As the sole principal investigator for this research project, he will receive a total of 1.2 billion KRW in research funding over five years, from this year until 2029.
Through this research project, Professor Lim will conduct studies targeting only tumor cells by utilizing ultrasound-based acoustic tweezer-sonogenetics technology.
Hot Picks Today
SpaceX Opens IPO Floodgates... Anthropic and OpenAI Push Valuations into the Trillions
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- "I'll Stop by Starbucks Tomorrow": People Power Chungbuk Committee and Geoje Mayoral Candidate Face Criticism for Alleged 5·18 Demeaning Remarks
- "From 119 Call to Hospital Transport"... Saving Sudden Cardiac Arrest Patients with AI and Video Calls
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
Professor Lim Haegyun stated, "We expect to precisely control the location and timing of immune cell therapy activation, thereby increasing treatment efficiency and minimizing side effects on surrounding healthy cells."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.